株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管インターベンション装置および末梢血管装置の世界市場予測 2021年:バルーン・ステント・カテーテル・IVCフィルター

Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) Forecasts to 2021

発行 MarketsandMarkets 商品コード 247573
出版日 ページ情報 英文 193 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.43円で換算しております。
Back to Top
心血管インターベンション装置および末梢血管装置の世界市場予測 2021年:バルーン・ステント・カテーテル・IVCフィルター Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) Forecasts to 2021
出版日: 2016年12月16日 ページ情報: 英文 193 Pages
概要

世界の心血管インターベンション・末梢血管装置市場規模は、2016年の218億3,000万米ドルから2021年までに314億7,000万米ドルへと7.1%のCAGR (年間複合成長率) で成長する見込みです。

当レポートでは、世界の心血管インターベンション・末梢血管装置市場について調査し、市場概要、製品・地域別の市場分析、競合環境の分析、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の心血管インターベンション・末梢血管装置市場における収益性の高い機会
  • 血管形成ステント市場:種類別
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 推進要因
    • 抑制要因
    • 機会
    • 課題
  • 規制の枠組み
  • 認可済み心血管インターベンション・末梢血管装置のリスト

第6章 血管形成術市場:処置別

  • イントロダクション
  • 経皮的バルーン血管形成術 (POBA)
  • 経皮経管冠動脈形成術 (PTCA)
  • 経皮経管的血管形成術 (PTA)

第7章 血管形成術用バルーン市場:種類別

  • イントロダクション
  • 血管形成術用バルーン材料
  • 血管形成術用バルーンプラットフォーム

第8章 血管形成術用ステント市場:種類別

  • イントロダクション
  • 血管形成術用ステント:種類別
  • 血管形成術用ステント:デリバリープラットフォーム別

第9章 カテーテル市場:種類別

  • イントロダクション
  • 血管形成術用カテーテル市場
  • 血管内超音波カテーテル (IVUSカテーテル) /光コヒーレンストモグラフィーカテーテル (OCTカテーテル) 市場
  • ガイディングカテーテル市場

第10章 血管内動脈瘤修復 (EVAR) ステントグラフト市場:種類別

  • イントロダクション
  • 腹部大動脈瘤
  • 胸部大動脈瘤

第11章 下大静脈 (IVC) フィルター市場:種類別

  • イントロダクション
  • 回収可能型フィルター
  • 永久留置型フィルター

第12章 プラーク修飾装置市場:種類別

  • イントロダクション
  • アテローム切除装置
  • 血栓切除装置

第13章 血流改変装置市場:種類別

  • イントロダクション
  • 塞栓保護装置
  • 慢性完全閉塞装置

第14章 付属品市場:種類別

  • イントロダクション
  • ガイドワイヤー
  • 血管閉鎖装置 (VCD)
  • イントロデューサシース
  • バルーン拡張装置

第15章 心血管インターベンション・末梢血管装置市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他の地域 (ROW)

第16章 競合環境

  • 概要
  • 戦略概要
  • 市場シェア分析
  • 競合状況・動向

第17章 企業プロファイル

  • イントロダクション
  • MEDTRONIC PLC
  • BOSTON SCIENTIFIC CORPORATION
  • ABBOTT LABORATORIES
  • CORDIS CORPORATION (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
  • ACCESSCLOSURE, INC. (A SUBSIDIARY OF CARDINAL HEALTH, INC.)
  • B. BRAUN MELSUNGEN AG
  • BIOSENSORS INTERNATIONAL GROUP LTD.
  • C.R. BARD, INC.
  • ST. JUDE MEDICAL, INC.
  • TERUMO CORPORATION

第18章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3456

The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1%.

  • On the basis of product, this market is broadly classified into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.
  • On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.
  • On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the IVUS/OCT segment is projected to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.
  • On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is projected to witness the highest growth in this market due to the rising incidence of smoking and hypertension.

Geographically, the interventional cardiology and peripheral vascular devices market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising incidence of cardiovascular diseases, rapidly growing geriatric population, and technological advancements.

Research Coverage:

In addition to comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles in this report comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the interventional cardiology and peripheral vascular devices market.

The key players in the interventional cardiology and peripheral vascular devices market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the interventional cardiology and peripheral vascular devices market. The report analyses the interventional cardiology and peripheral vascular devices market by angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the interventional cardiology and peripheral vascular devices market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional cardiology and peripheral vascular devices market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various interventional cardiology and peripheral vascular devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional cardiology and peripheral vascular devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
  • 2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LUCRATIVE OPPORTUNITIES IN THE GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
  • 4.2. ANGIOPLASTY STENTS MARKET, BY TYPE
  • 4.3. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising geriatric population
      • 5.2.1.2. Increasing demand for minimally invasive angioplasty treatments
      • 5.2.1.3. Technological advancements in interventional cardiology and peripheral vascular devices
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Availability of effective conventional first-level treatments
      • 5.2.2.2. Product failures and recalls
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Bioabsorbable stents
      • 5.2.3.2. Emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Varying reimbursements
      • 5.2.4.2. Entry barriers for new players
  • 5.3. REGULATORY FRAMEWORK
  • 5.4. LIST OF APPROVED INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES

6. ANGIOPLASTY MARKET, BY PROCEDURE

  • 6.1. INTRODUCTION
  • 6.2. PLAIN OLD BALLOON ANGIOPLASTY (POBA)
  • 6.3. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
  • 6.4. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA)

7. ANGIOPLASTY BALLOONS MARKET, BY TYPE

  • 7.1. INTRODUCTION
    • 7.1.1. OLD/NORMAL BALLOONS
    • 7.1.2. CUTTING AND SCORING BALLOONS
    • 7.1.3. DRUG-ELUTING BALLOONS
  • 7.2. ANGIOPLASTY BALLOON MATERIAL
    • 7.2.1. NON-COMPLIANT BALLOONS
    • 7.2.2. SEMI-COMPLIANT BALLOONS
    • 7.2.3. LOW-COMPLIANT BALLOONS
  • 7.3. ANGIOPLASTY BALLOON PLATFORMS
    • 7.3.1. OVER-THE-WIRE BALLOON CATHETERS
    • 7.3.2. RAPID EXCHANGE (RX) BALLOON CATHETERS
    • 7.3.3. FIXED-WIRE BALLOON CATHETERS

8. ANGIOPLASTY STENTS MARKET, BY TYPE

  • 8.1. INTRODUCTION
  • 8.2. ANGIOPLASTY STENTS, BY TYPE
    • 8.2.1. BARE-METAL STENTS
    • 8.2.2. DRUG-ELUTING STENTS
    • 8.2.3. BIOABSORBABLE STENTS
  • 8.3. ANGIOPLASTY STENTS, BY DELIVERY PLATFORM
    • 8.3.1. SELF-EXPANDING STENT
    • 8.3.2. BALLOON-EXPANDABLE STENT

9. CATHETERS MARKET, BY TYPE

  • 9.1. INTRODUCTION
  • 9.2. ANGIOGRAPHY CATHETERS
  • 9.3. IVUS/OCT CATHETERS
  • 9.4. GUIDING CATHETERS

10. ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET, BY TYPE

  • 10.1. INTRODUCTION
  • 10.2. ABDOMINAL AORTIC ANEURYSMS
  • 10.3. THORACIC AORTIC ANEURYSMS

11. INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE

  • 11.1. INTRODUCTION
  • 11.2. RETRIEVABLE FILTERS
  • 11.3. PERMANENT FILTERS

12. PLAQUE MODIFICATION DEVICES MARKET, BY TYPE

  • 12.1. INTRODUCTION
  • 12.2. ATHERECTOMY DEVICES
  • 12.3. THROMBECTOMY DEVICES

13. HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE

  • 13.1. INTRODUCTION
  • 13.2. EMBOLIC PROTECTION DEVICES
  • 13.3. CHRONIC TOTAL OCCLUSION DEVICES

14. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET, BY TYPE

  • 14.1. INTRODUCTION
  • 14.2. GUIDEWIRES
  • 14.3. VASCULAR CLOSURE DEVICES
  • 14.4. INTRODUCER SHEATHS
  • 14.5. BALLOON INFLATION DEVICES

15. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION

  • 15.1. INTRODUCTION
  • 15.2. NORTH AMERICA
    • 15.2.1. U.S.
    • 15.2.2. CANADA
  • 15.3. EUROPE
  • 15.4. ASIA
  • 15.5. REST OF THE WORLD

16. COMPETITIVE LANDSCAPE

  • 16.1. OVERVIEW
  • 16.2. STRATEGIC OVERVIEW
  • 16.3. MARKET SHARE ANALYSIS
  • 16.4. COMPETITIVE SITUATION AND TRENDS
    • 16.4.1. REGULATORY APPROVALS
    • 16.4.2. ACQUISITIONS
    • 16.4.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 16.4.4. PRODUCT LAUNCHES
    • 16.4.5. OTHER DEVELOPMENTS

17. COMPANY PROFILE (Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*

  • 17.1. INTRODUCTION
  • 17.2. MEDTRONIC PLC
  • 17.3. BOSTON SCIENTIFIC CORPORATION
  • 17.4. ABBOTT LABORATORIES
  • 17.5. CORDIS CORPORATION (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
  • 17.6. ACCESSCLOSURE, INC. (A SUBSIDIARY OF CARDINAL HEALTH, INC.)
  • 17.7. B. BRAUN MELSUNGEN AG
  • 17.8. BIOSENSORS INTERNATIONAL GROUP LTD.
  • 17.9. C.R. BARD, INC.
  • 17.10. ST. JUDE MEDICAL, INC.
  • 17.11. TERUMO CORPORATION

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

18. APPENDIX

  • 18.1. INSIGHTS OF INDUSTRY EXPERTS
  • 18.2. DISCUSSION GUIDE
  • 18.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 18.5. AVAILABLE CUSTOMIZATIONS
  • 18.6. RELATED REPORTS
  • 18.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE MARKET SUMMARY
  • TABLE 2: LIST OF U.S. FDA-APPROVED PRODUCTS
  • TABLE 3: LIST OF CE-MARKED PRODUCTS
  • TABLE 4: GLOBAL ANGIOPLASTY MARKET SIZE, BY PROCEDURE, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 5: GLOBAL ANGIOPLASTY MARKET SIZE, BY REGION, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 6: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY MARKET SIZE, BY REGION, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 7: PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MARKET SIZE, BY REGION, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 8: GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: OLD/NORMAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: NORTH AMERICA: OLD/NORMAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: CUTTING AND SCORING ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: NORTH AMERICA: CUTTING AND SCORING ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: DRUG-ELUTING ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: DRUG-ELUTING ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL ANGIOPLASTY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: ANGIOPLASTY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: BARE-METAL ANGIOPLASTY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: NORTH AMERICA: BARE-METAL ANGIOPLASTY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: DRUG-ELUTING ANGIOPLASTY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: DRUG-ELUTING ANGIOPLASTY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: BIOABSORBABLE ANGIOPLASTY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: BIOABSORBABLE ANGIOPLASTY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL CATHETERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL CATHETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CATHETERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL ANGIOGRAPHY CATHETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: ANGIOGRAPHY CATHETERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL IVUS/OCT CATHETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL IVUS/OCT CATHETERS, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 33: NORTH AMERICA: IVUS/OCT CATHETERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL GUIDING CATHETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL GUIDING CATHETERS, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 36: NORTH AMERICA: GUIDING CATHETERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL EVAR STENT GRAFTS, BY TYPE, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 40: GLOBAL EVAR STENT GRAFTS, BY REGION, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 41: NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL EVAR STENT GRAFTS MARKET SIZE FOR ABDOMINAL AORTIC ANEURYSMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL EVAR STENT GRAFTS FOR ABDOMINAL AORTIC ANEURYSMS, BY REGION, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 44: NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE FOR ABDOMINAL AORTIC ANEURYSMS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: GLOBAL EVAR STENT GRAFTS MARKET SIZE FOR THORACIC AORTIC ANEURYSMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL EVAR STENT GRAFTS FOR THORACIC AORTIC ANEURYSMS, BY REGION, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 47: NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE FOR THORACIC AORTIC ANEURYSMS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: GLOBAL IVC FILTERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL IVC FILTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: GLOBAL IVC FILTERS, BY TYPE, 2014-2021 (UNITS)
  • TABLE 51: GLOBAL IVC FILTERS, BY REGION, 2014-2021 (UNITS)
  • TABLE 52: NORTH AMERICA: IVC FILTERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: GLOBAL RETRIEVABLE IVC FILTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: GLOBAL RETRIEVABLE IVC FILTERS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 55: NORTH AMERICA: RETRIEVABLE IVC FILTERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: GLOBAL PERMANENT IVC FILTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: GLOBAL PERMANENT IVC FILTERS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 58: NORTH AMERICA: PERMANENT IVC FILTERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: GLOBAL PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: GLOBAL PLAQUE MODIFICATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 62: GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 63: NORTH AMERICA: ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 68: NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: GLOBAL CHRONIC TOTAL OCCLUSION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 72: NORTH AMERICA: CHRONIC TOTAL OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 73: GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 75: GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 76: NORTH AMERICA: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 77: GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 78: GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 79: NORTH AMERICA: GUIDEWIRES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 81: GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 82: NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 83: GLOBAL INTRODUCER SHEATHS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 84: GLOBAL INTRODUCER SHEATHS MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 85: NORTH AMERICA: INTRODUCER SHEATHS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 86: GLOBAL BALLOON INFLATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 87: GLOBAL BALLOON INFLATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 88: NORTH AMERICA: BALLOON INFLATION DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 89: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 90: NORTH AMERICA: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 91: NORTH AMERICA: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 92: NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: NORTH AMERICA: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: NORTH AMERICA: CATHETERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: NORTH AMERICA: IVC FILTERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 99: NORTH AMERICA: ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 100: U.S.: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 101: U.S.: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: U.S.: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: U.S.: CATHETERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: U.S.: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: U.S.: IVC FILTERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 106: U.S.: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 107: U.S.: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: U.S.: ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 109: CANADA: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 110: CANADA: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 111: CANADA: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: CANADA: CATHETERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: CANADA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 114: CANADA: IVC FILTERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: CANADA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 116: CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 117: CANADA: ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 118: EUROPE: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 119: EUROPE: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 120: EUROPE: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 121: EUROPE: CATHETERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: EUROPE: IVC FILTERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 124: EUROPE: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: EUROPE: ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 127: ASIA: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 128: ASIA: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: ASIA: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 130: ASIA: CATHETERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 131: ASIA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: ASIA: IVC FILTERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: ASIA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 134: ASIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 135: ASIA: ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 136: ROW: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 137: ROW: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 138: ROW: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 139: ROW: CATHETERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 140: ROW: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 141: ROW: IVC FILTERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: ROW: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 143: ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 144: ROW: ACCESSORIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 145: MARKET DEVELOPMENTS, 2013-2016
  • TABLE 146: REGULATORY APPROVALS, 2013-2016
  • TABLE 147: ACQUISITIONS, 2013-2016
  • TABLE 148: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 149: PRODUCT LAUNCHES, 2013-2016
  • TABLE 150: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 7: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 8: CATHETERS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 9: ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 10: INFERIOR VENA CAVA (IVC) FILTERS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 11: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 12: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 13: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 14: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2016 VS. 2021 (USD BILLION)
  • FIGURE 15: INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES - AN IMPORTANT GROWTH DRIVER FOR THE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 16: DRUG-ELUTING STENTS TO HOLD THE LARGEST SHARE IN THE ANGIOPLASTY STENTS MARKET IN 2016
  • FIGURE 17: THE ASIAN MARKET TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA AND EUROPE ARE MATURE MARKETS FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES
  • FIGURE 19: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 20: PTCA PROCEDURE WILL DOMINATE THE MARKET IN THE FORECAST PERIOD
  • FIGURE 21: DRUG-ELUTING BALLOONS TO DOMINATE THE ANGIOPLASTY BALLOONS MARKET IN 2021
  • FIGURE 22: DRUG-ELUTING STENTS WILL DOMINATE THE ANGIOPLASTY STENTS MARKET IN THE FORECAST PERIOD
  • FIGURE 23: IVUS/OCT SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 24: ABDOMINAL AORTIC ANEURYSMS WILL DOMINATE THE GLOBAL EVAR STENT GRAFTS MARKET IN THE FORECAST PERIOD
  • FIGURE 25: RETRIEVABLE FILTERS WILL DOMINATE IVC FILTERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: ATHERECTOMY DEVICES TO DOMINATE THE PLAQUE MODIFICATION DEVICES MARKET IN THE FORECAST PERIOD
  • FIGURE 27: EMBOLIC PROTECTION DEVICES TO DOMINATE THE HEMODYNAMIC FLOW ALTERATION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: GUIDEWIRES TO DOMINATE THE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 29: THE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET IN ASIA IS EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 30: NORTH AMERICA: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
  • FIGURE 31: ASIA: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
  • FIGURE 32: REGULATORY APPROVALS-KEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2013 AND 2016
  • FIGURE 33: GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 34: FINANCIAL PERFORMANCE OF LEADING MARKET PLAYERS (2013-2015)
  • FIGURE 35: COMPANY SNAPSHOT: MEDTRONIC PLC
  • FIGURE 36: COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION
  • FIGURE 37: COMPANY SNAPSHOT: ABBOTT LABORATORIES
  • FIGURE 38: COMPANY SNAPSHOT: JOHNSON & JOHNSON SERVICES, INC.
  • FIGURE 39: COMPANY SNAPSHOT: CARDINAL HEALTH, INC.
  • FIGURE 40: COMPANY SNAPSHOT: B BRAUN MELSUNGEN AG
  • FIGURE 41: COMPANY SNAPSHOT: BIOSENSORS INTERNATIONAL GROUP LTD.
  • FIGURE 42: COMPANY SNAPSHOT: C.R. BARD, INC.
  • FIGURE 43: COMPANY SNAPSHOT: ST. JUDE MEDICAL, INC.
  • FIGURE 44: COMPANY SNAPSHOT: TERUMO CORPORATION
Back to Top